CAPTRUST FINANCIAL ADVISORS - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 155 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2021. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q2 2022$8,000
+100.0%
6,7500.0%0.00%
Q1 2022$4,000
-42.9%
6,7500.0%0.00%
Q4 2021$7,000
-50.0%
6,750
-13.6%
0.00%
Q3 2021$14,000
-22.2%
7,810
+15.7%
0.00%
Q2 2021$18,000
-33.3%
6,750
-10.7%
0.00%
Q1 2021$27,000
+145.5%
7,556
+183.0%
0.00%
Q3 2019$11,0002,6700.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q1 2021
NameSharesValueWeighting ↓
Belmont Global Advisors, Inc. 2,564,925$11,132,0008.99%
Essex Woodlands Management, Inc. 2,764,908$11,330,0005.70%
Third Security, LLC 17,815,708$77,320,0003.68%
MSD Partners, L.P. 2,750,000$11,935,0000.49%
SFMG, LLC 99,850$433,0000.15%
GM Advisory Group, LLC 12,500$54,0000.06%
Geduld E E 25,000$109,0000.05%
WESTPORT RESOURCES MANAGEMENT INC 30,500$132,0000.04%
Janney Montgomery Scott LLC 335,571$1,456,378,0000.04%
WFG Advisors, LP 48,040$208,0000.03%
View complete list of ZIOPHARM ONCOLOGY INC shareholders